Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving glucose or galactose
Patent
1995-04-07
1997-12-09
Gitomer, Ralph
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving glucose or galactose
422 56, 422 57, 436169, C12Q 154, G01N 3122
Patent
active
056959494
ABSTRACT:
The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative of the subject's immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. Optionally, other analytes indicative of glycemic condition, such as ketone bodies or fatty acid derivatives, can also be measured. The present invention also provides a method of diagnosing diabetes. The invention additionally provides a method for analyzing the concentration of fructosamine in less than or equal to five minutes without the use of a reaction accelerator.
REFERENCES:
patent: 3552929 (1971-01-01), Fields et al.
patent: 3802842 (1974-04-01), Lange et al.
patent: 3809605 (1974-05-01), Schmitt et al.
patent: 3897214 (1975-07-01), Lange et al.
patent: 3973849 (1976-08-01), Jackson et al.
patent: 4042335 (1977-08-01), Clement
patent: 4050898 (1977-09-01), Goffe
patent: 4223995 (1980-09-01), Fletcher
patent: 4269605 (1981-05-01), Dean et al.
patent: 4397956 (1983-08-01), Maggio
patent: 4478744 (1984-10-01), Mezei et al.
patent: 4482251 (1984-11-01), Saylor
patent: 4545382 (1985-10-01), Higgins et al.
patent: 4642295 (1987-02-01), Baker
patent: 4645742 (1987-02-01), Baker
patent: 4681444 (1987-07-01), Ferber et al.
patent: 4729657 (1988-03-01), Cooper et al.
patent: 4744657 (1988-05-01), Aralis et al.
patent: 4806468 (1989-02-01), Wagner et al.
patent: 4852025 (1989-07-01), Herpchbohm
patent: 4866644 (1989-09-01), Shenk et al.
patent: 4935346 (1990-06-01), Phillips et al.
patent: 4956301 (1990-09-01), Ismail et al.
patent: 4999582 (1991-03-01), Parks et al.
patent: 5002893 (1991-03-01), Rosenthal
patent: 5049487 (1991-09-01), Phillips
patent: 5059394 (1991-10-01), Phillips et al.
patent: 5110745 (1992-05-01), Kricka et al.
patent: 5169787 (1992-12-01), Knappe et al.
patent: 5183739 (1993-02-01), Cohen
patent: 5206144 (1993-04-01), Zeuthen et al.
patent: 5215716 (1993-06-01), Arai
patent: 5243516 (1993-09-01), White
patent: 5258163 (1993-11-01), Krause et al.
patent: 5271895 (1993-12-01), McCroskey et al.
patent: 5281395 (1994-01-01), Markart et al.
patent: 5284777 (1994-02-01), Rosenthal et al.
patent: 5304468 (1994-04-01), Phillips et al.
patent: 5366868 (1994-11-01), Sakamoto
patent: 5384239 (1995-01-01), Saunders
patent: 5470752 (1995-11-01), Burd et al.
Johnson et al., "Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control." Clinica Chimica Acta, 127:87-95 (1982).
Caines et al., "Colorimetric determination of non-enzymatically glycated albumin," Clinical Biochemistry, 19:26-30 (Feb. 1986).
David A. Armbruster, "Fructosamine: Structure, Analysis, and Clinical Usefulness." Clinical Chemistry, 33(12):2153-2163 (1987).
Michael A. Rosen, "Protein-Bound glucose as a screening test for diabetes." Hospital Practice, 27:59-61 (1992).
Goldstein et al., "Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complications trial." Clin. Chem., 40(8):1637-1640 (1994).
Benjamin and Sacks, "Glycated protein update: implications of recent studies, including the diabetes control and complications trial." Clin. Chem., 40(5):683-687 (1994).
Guillausseau et al., "Comparison of HbA.sub.1 and fructosamine in diagnosis of glucose-tolerance abnormalities." Diabetes Care 13(8):898-890 (1990).
Thbsalemans et al., "The value of HbA.sub.1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes." Ann. Clin. Biochem., 24:447-452 (1987).
Baker et al., "Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus." British Med. J., 287:863-867 (1983).
Dods and Bolmey, "Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus." Clin. Chem. 25(5):764-768 (1979).
Dix et al., "Glycohemoglobin and glucose tolerance tests compared as indicators of borderline diabetes." Clin. Chem., 25(6):877-879 (1979).
Pamphlet Insert to the Abbott Vision System Oct. 1993.
Pamphlet Insert to the Lifescan, One Touch II Blood Glucose Meter 1990.
Jason Kahn, "Tight blood glucose control shown beneficial for diabetes." Clin. Chem. News, 19(9) (1993).
Goldstein and Little, "The impact of the diabetes control and complications trial on the clinical laboratory." Viewpoints, 4 (1993).
Cefalu et al., "Serum fructosamine as a screening test for diabetes in the elderly: a pilot study." JAGS, 41:1090-1094 (1993).
Larsen et al., "Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus." New England J. of Med., 323(15):1021-1025 (1990).
Shima K., The Relative Value of Glycated Albumin, Hemoglobin A1c and Fructosamine When Screening for Diabetes Mellitus, Diabetes Research and Clinical Practice, 7 243-250, 1989.
Rowe DJF, The Measurement and Clinical Significance of Glycated Proteins, Practical Diabetes 6(6) 256-260, Nov. 1989.
Armbruster D., Diabetes Mellitus, Protein Glycation, and Laboratory Assays for Monitoring Long-Term Glycemic Control, Clinical Lab Science 3(3) 184-188, May 1990.
Guillausseau PJ, Comparison of HbA1 and Fructosamine in Diagnosis of Glucose Tolerance Abnormalities, Diabetes Care 11(8) 898-900, Aug. 1990.
Candiloros H., Decreased Erythrocyte Membrane Fluidity in Poorly Controlled IDDM, 18(4) 549-551, Diabetes Care, Apr. 1995.
Burd John F.
Galen Robert S.
Hoblitzell Talei
Neyer Gebhard
Gitomer Ralph
LXN Corp.
LandOfFree
Combined assay for current glucose level and intermediate or lon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined assay for current glucose level and intermediate or lon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined assay for current glucose level and intermediate or lon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1606762